Abbott Laboratories Detailed Financials

Full historical quarterly statements

Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue12.59B11.16B11.46B11.37B11.14B10.36B10.97B10.63B
Cost of Goods Sold5.29B4.88B4.92B5.03B4.85B4.91B5.38B5.21B
Gross Profit7.30B6.28B6.54B6.34B6.29B5.44B5.60B5.43B
R&D Expenses882.0M756.0M735.0M785.0M732.0M703.0M728.0M713.0M
Operating Expenses5.52B4.44B4.29B4.31B4.24B3.76B3.61B3.61B
Operating Income1.78B1.84B2.25B2.06B2.05B1.69B1.99B1.82B
Other Income / Gains-258.0M-393.0M107.0M123.0M98.0M90.0M40.0M122.0M
Net Income928.0M1.08B1.78B1.64B1.78B1.32B9.23B1.65B
EPS (Diluted)0.530.621.020.941.020.7585.330.95
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.580.5630.570.5570.5640.5260.510.51
General And Administrative Expenses003.13B00000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses3.98B3.26B3.13B3.10B3.09B3.05B2.88B2.90B
Other Expenses658.0M422.0M422.0M420.0M411.0M000
Cost And Expenses10.81B9.32B9.21B9.31B9.09B8.67B8.98B8.82B
Interest Income0106.0M78.0M77.0M71.0M82.0M91.0M91.0M
Interest Expense299.0M174.0M120.0M44.0M121.0M134.0M152.0M166.0M
Depreciation And Amortization0730.0M422.0M791.0M777.0M756.0M807.0M801.0M
Ebitda1.78B2.25B2.82B3.09B3.05B2.67B2.99B2.91B
Ebitdaratio0.1420.2010.2460.2720.2740.2580.2720.273
Operating Income Ratio0.1420.1650.1960.1810.1840.1630.1810.171
Income Before Tax1.52B1.45B2.36B2.18B2.15B1.78B2.03B1.94B
Income Before Tax Ratio0.1210.130.2060.1920.1930.1720.1850.182
Income Tax Expense596.0M372.0M582.0M536.0M371.0M453.0M-7.20B294.0M
Net Income Ratio0.0740.0960.1550.1450.160.1280.8410.155
Epsdiluted0.530.621.020.941.010.7585.270.94
Weighted Average Shs Out1.74B1.75B1.75B1.75B1.74B1.75B1.73B1.73B
Weighted Average Shs Out Dil1.74B1.75B1.75B1.75B1.75B1.75B1.75B1.75B